Stay updated on BELINDA Clinical Trial: Tisagenlecleucel in B-cell NHL
Sign up to get notified when there's something new on the BELINDA Clinical Trial: Tisagenlecleucel in B-cell NHL page.

Latest updates to the BELINDA Clinical Trial: Tisagenlecleucel in B-cell NHL page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe page’s revision/version label was updated from v3.5.2 to v3.5.3, indicating a site software/version change rather than a change to the trial information displayed.SummaryDifference0.0%

- Check28 days agoChange DetectedPage revision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check35 days agoChange DetectedEnrollment (Actual) updated to 330 on 2026-04-08. The previous value 331 was removed on 2026-03-02.SummaryDifference0.1%

- Check56 days agoChange DetectedRecruitment status updated to Completed with new sites added (Emory University; Sapporo and Sendai in Japan). The prior Active, not recruiting status and an older site entry were removed, and the revision was updated to v3.5.0.SummaryDifference0.4%

- Check70 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3. This appears to be a minor version update with no visible changes to the study details or page content.SummaryDifference0.0%

- Check92 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2; this change appears to be a software/version update with no modifications to study data, eligibility criteria, or user-facing content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to BELINDA Clinical Trial: Tisagenlecleucel in B-cell NHL
Enter your email address, and we'll notify you when there's something new on the BELINDA Clinical Trial: Tisagenlecleucel in B-cell NHL page.